Combined Dupilumab and House Dust Mite Sublingual Immunotherapy Provides Sustained Clinical and Immunologic Benefits in Severe Atopic Dermatitis: 3-Year Results of a Randomized Controlled Study.
https://www.medspoke.co/channel_journal?id=803&tap_id=17644